Evidence map›Paper›PMID 29956073›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2019

iTRAQ-based proteomic analysis of DMH-induced colorectal cancer in mice reveals the expressions of β-catenin, decorin, septin-7, and S100A10 expression in 53 cases of human hereditary polyposis colorectal cancer.

G Liu, F Fei, J Qu, X Wang, Y Zhao, Y Li, S Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Decorin: matrix-based pan-cancer tumor suppressor.Molecular and cellular biochemistry · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Clinical significance of serum S100A10 in lung cancer.The Journal of international medical research · 2021
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

G LiuDepartment of Pathology, Tianjin Union Medical Center, Tianjin, 300121, People's Republic of China.
F FeiNankai University School of Medicine, Nankai University, Tianjin, 300071, People's Republic of China.
J QuNankai University School of Medicine, Nankai University, Tianjin, 300071, People's Republic of China.
X WangDepartment of Pathology, Tianjin Union Medical Center, Tianjin, 300121, People's Republic of China.
Y ZhaoDepartment of General Surgery, Tianjin Union Medical Center, Tianjin, 300121, People's Republic of China.
Y LiDepartments of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, 300121, People's Republic of China.
S ZhangDepartment of Pathology, Tianjin Union Medical Center, Tianjin, 300121, People's Republic of China. zhangshiwu666@aliyun.com.ORCID http://orcid.org/0000-0002-5052-2283
Tianjin People's Hospital · CNNankai University · CNTianjin University of Traditional Chinese Medicine · CNUnion Hospital · CN

Funding

National Natural Science Foundation of China 81472729National Natural Science Foundation of China 81672426
6 · The paper itself

Abstract

purposeThe aim of this study is to explore the roles of β-catenin, decorin, septin-7, and S100A10 expression in colorectal cancer development.

methodsTwenty-five BALB/c mice were divided into five groups; four groups were administrated N,N-dimethylhydrazine for 0, 10, 15, and 20 weeks, and one group was administrated normal saline for 20 weeks. The colons were collected for histopathological analysis. Protein samples prepared from the frozen colon tissues of mice treated with N,N-dimethylhydrazine for the different time points were evaluated using the isobaric tags for relative and absolute quantification (iTRAQ) labeling technique coupled with the 2D liquid chromatography-tandem mass spectrometry analysis. Based on the proteomic analysis results, immunohistochemical staining of β-catenin, decorin, septin-7, and S100A10 was performed in paraffin-embedded mice colorectal tissue, and 53 cases of human hereditary polyposis colorectal cancer samples.

resultsColorectal cancer was observed in mice treated with N,N-dimethylhydrazine for 20 weeks, and adenomas were observed in mice subjected to the 10-, and 15-week treatments. Seventy-two differentially expressed proteins were involved in the development of cancer as per the iTRAQ and spectrometry analysis. In normal epithelium, adenoma, and cancer from human hereditary polyposis colorectal cancer, S100A10 expression (c2 = 100.989, P = 0.000) was highest in cancer, whereas decorin (c2 = 12.852, P = 0.002) and septin-7 (c2 = 66.519, P = 0.002) expressions were highest in the normal epithelium, which was confirmed via immunohistochemical staining.

conclusionsThe subcellular localization of β-catenin and decorin, septin-7, and S100A10 expressions are associated with the development of colorectal cancer in mice after N,N-dimethylhydrazine treatment and in human hereditary polyposis colorectal cancers.

Indexed as

Adenomatous Polyposis ColiAdultAnimalsAnnexin A2beta CateninBiomarkers, TumorCarcinogensColorectal NeoplasmsDecorinDimethylhydrazinesFemaleHumansMaleMiceMice, Inbred BALB CMiddle AgedAnnexin A2beta CateninBiomarkers, TumorCarcinogensDecorinDimethylhydrazinesS100 Calcium Binding Protein A10S100 ProteinsSeptinsColorectal cancerDifferentially expressed proteinsHereditary polyposis colorectal cancerN,N-dimethylhydrazine

Identifiers

PMID29956073
OpenAlexW2811143332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.